AGC Inc. (“AGC”) announces that on 2 April 2020 local Milan time it has filed with Consob – pursuant to and for the purposes of Article 102, paragraph 3, of Legislative Decree no. 58 of 24 February 1998, as subsequently amended (the“CLFI”), as well as Article 37-ter of the Issuers’ Regulation – the offer document (the “Offer Document”), intended for publication, related to the voluntary public tender offer (the “Offer”) launched by AGC, through a corporate vehicle wholly owned by AGC (the “Offeror”), pursuant to Articles 102 et seq. of the CLFI, for the purchase of up to no. 463,450,672 ordinary shares (the "Shares") of MolMed S.p.A. (“MolMed” or the “Issuer”), representing all the shares of the Issuer in circulation as at the date of this press release.
The Offer Document will be published at the end of the review carried out by Consob pursuant to Article 102, paragraph 4, of the CLFI.
＊NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
AGC Inc.(Headquarters: Tokyo, President & CEO: Takuya Shimamura) is the parent company of the AGC Group, a world-leading glass solution provider and supplier of flat, automotive and display glass, chemicals, ceramics and other high-tech materials and components. Based on more than a century of technical innovation, the AGC Group has developed a wide range of cutting-edge products. The AGC Group employs some 55,000 people worldwide and generates annual sales of approximately 1.5 trillion Japanese yen through business in about 30 countries. For more information, please visit